D'Orazi, Gabriella
 Distribuzione geografica
Continente #
AS - Asia 1.307
SA - Sud America 634
NA - Nord America 278
EU - Europa 209
AF - Africa 49
OC - Oceania 1
Totale 2.478
Nazione #
SG - Singapore 632
BR - Brasile 550
CN - Cina 256
US - Stati Uniti d'America 200
VN - Vietnam 153
IT - Italia 99
HK - Hong Kong 89
MX - Messico 50
AR - Argentina 39
BD - Bangladesh 31
GB - Regno Unito 27
IN - India 26
FR - Francia 24
IQ - Iraq 21
ID - Indonesia 17
ZA - Sudafrica 17
SA - Arabia Saudita 15
UA - Ucraina 14
EC - Ecuador 11
RU - Federazione Russa 10
UZ - Uzbekistan 10
PK - Pakistan 9
CA - Canada 8
CO - Colombia 8
KE - Kenya 8
MA - Marocco 7
DE - Germania 6
JO - Giordania 6
NL - Olanda 6
NP - Nepal 6
UY - Uruguay 6
KZ - Kazakistan 5
PY - Paraguay 5
TN - Tunisia 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
BO - Bolivia 4
HN - Honduras 4
IL - Israele 4
PE - Perù 4
TR - Turchia 4
BH - Bahrain 3
DO - Repubblica Dominicana 3
EG - Egitto 3
PT - Portogallo 3
CR - Costa Rica 2
DK - Danimarca 2
ES - Italia 2
ET - Etiopia 2
JM - Giamaica 2
JP - Giappone 2
LA - Repubblica Popolare Democratica del Laos 2
OM - Oman 2
PA - Panama 2
RE - Reunion 2
RS - Serbia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AD - Andorra 1
AL - Albania 1
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BF - Burkina Faso 1
BG - Bulgaria 1
BS - Bahamas 1
CH - Svizzera 1
CL - Cile 1
GF - Guiana Francese 1
HU - Ungheria 1
IE - Irlanda 1
KR - Corea 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
ML - Mali 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PL - Polonia 1
RO - Romania 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UG - Uganda 1
YE - Yemen 1
Totale 2.478
Città #
Singapore 314
Beijing 146
Hong Kong 87
Rome 71
Ho Chi Minh City 65
Ashburn 45
São Paulo 37
Mexico City 36
Hanoi 32
Rio de Janeiro 18
Belo Horizonte 16
Curitiba 13
Baghdad 10
Campinas 10
Tashkent 9
Santa Clara 8
Brasília 7
Dhaka 7
Amman 6
Jeddah 6
Biên Hòa 5
Casablanca 5
Goiânia 5
Haiphong 5
Montevideo 5
Nairobi 5
Porto Alegre 5
Quito 5
Recife 5
Riyadh 5
Salvador 5
Diadema 4
Erbil 4
Fortaleza 4
Frankfurt am Main 4
Guarulhos 4
Kathmandu 4
Lima 4
Osasco 4
Quimilí 4
Ribeirão das Neves 4
Santa Cruz 4
Sorocaba 4
Thái Bình 4
Volta Redonda 4
Baku 3
Boa Vista 3
Bogotá 3
Buenos Aires 3
Bình Dương 3
Bắc Giang 3
Canoas 3
Caxias do Sul 3
Dammam 3
Dubai 3
Durban 3
Feira de Santana 3
Governador Valadares 3
Jequié 3
Joinville 3
Kyiv 3
La Plata 3
Lahore 3
London 3
Maricá 3
Marília 3
Mauá 3
Newark 3
Piracicaba 3
Pirapora 3
Pretoria 3
Quảng Ngãi 3
Quận Bình Thạnh 3
São Gonçalo 3
São José 3
Thái Nguyên 3
Viamão 3
Addis Ababa 2
Ahmedabad 2
Aktobe 2
Alvorada 2
Amsterdam 2
Angra dos Reis 2
Ankara 2
Aparecida de Goiânia 2
Araguaína 2
Araraquara 2
Araucária 2
Araxá 2
Arraial do Cabo 2
Asunción 2
Atlanta 2
Barbacena 2
Barra da Estiva 2
Benito Juarez 2
Bexley 2
Blumenau 2
Bom Princípio 2
Bạc Liêu 2
Cachoeirinha 2
Totale 1.196
Nome #
HIPK2 as a Novel Regulator of Fibrosis 26
Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: clue for novel anticancer therapies 24
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 22
KSHV infection skews macrophage polarisation towards M2-like/TAM and activates Ire1 α-XBP1 axis up-regulating pro-tumorigenic cytokine release and PD-L1 expression 22
N6-Methyldeoxyadenosine, a nucleoside commonly found in prokaryotes, induces C2C12 myogenic differentiation 21
HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic Diseases 21
ATF6 prevents DNA damage and cell death in colon cancer cells undergoing ER stress 21
A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status 21
Clearing mutant p53 with natural compounds: implication for anticancer therapeutical approaches 20
Zn(II)-curc targets p53 in thyroid cancer cells 20
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 20
ATF6 supports lysosomal function in tumor cells to enable ER stress-activated macroautophagy and CMA: impact on mutant TP53 expression 19
P62/SQSTM1/Keap1/NRF2 Axis Reduces Cancer Cells Death-Sensitivity in Response to Zn(II)-Curcumin Complex 19
Targeting mutant p53 in cancer: the latest insights 19
Azurin modulates the association of Mdm2 with p53: SPR evidence from interaction of the full-length proteins 19
Targeting hypoxia in tumor: a new promising therapeutic strategy 18
Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways 18
NRF2 and Bip Interconnection Mediates Resistance to the Organometallic Ruthenium-Cymene Bisdemethoxycurcumin Complex Cytotoxicity in Colon Cancer Cells 18
HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage 18
Aspetti ultastrutturali di lingua e paradenzio di ratti alimentati con dieta aproteica 18
Use of zinc in combination with chemotherapy for treating cancer 18
Establishment and characterization of a human continuous cell line from a IVs neuroblastoma 18
Zinc supplementation augments in vivo antitumor effect of chemotherapy by restoring p53 function 17
Sintesi di laminina da parte delle cellule NK e dei linfociti T di ratto 17
Analysis of type V collagen as a component of breast carcinoma desmoplastic stroma 17
Activation of p53-dependent apoptosis in HIPK2 depleted tumor cells: an approach of combination therapy with drug, zinc, and deacetylase inhibitors 17
Zinco come adiuvante nelle chemioterapie per la riattivazione del pathway oncosoppressorio HIPK2/p53 17
The Role of Autophagy in Brain Tumors 16
Zinc supplementation is required for the cytotoxic and immunogenic effects of chemotherapy in chemoresistant p53-functionally deficient cells 16
Ultrastructurale evidence of the mechanism responsible for Interleukin-4 activated rejection of a spontaneous murine adenocarcinoma 16
HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations 16
Expression and synthesis of fibronectin and laminin by an intestinal epithelial cell line 16
SAHA/5-AZA Enhances Acetylation and Degradation of mutp53, Upregulates p21 and Downregulates c-Myc and BRCA-1 in Pancreatic Cancer Cells 16
Mutant P53, stabilized by its interplay with HSP90, activates a positive feed-back loop between NRF2 and P62 that induces chemo-resistance to apigenin in pancreatic cancer cells 16
VPA and TSA Interrupt the Interplay between mutp53 and HSP70, Leading to CHK1 and RAD51 Down-Regulation and Sensitizing Pancreatic Cancer Cells to AZD2461 PARP Inhibitor 16
Aspetti differenziativi in una coltura di cellule dell'epitelio intestinale e sintesi di matrice extracellulare 16
Anticancer effect of AZD2461 PARP inhibitor against colon cancer cells carrying wt or dysfunctional p53 16
Post-Translational Modifications (PTMs) of mutp53 and Epigenetic Changes Induced by mutp53 16
Interplay between endoplasmic reticulum (ER) stress and autophagy induces mutant p53H273 degradation 16
HIPK2 downregulates vimentin and inhibits breast cancer cell invasion 16
Analysis of MMP-2 and MMP-9 activity in prostate fluids, tissue homogenates and primary cell culture from patients with prostate cancer or benign prostate disease 16
Immunohystochemical distribution of type IV gelatinase A and type V collagen in ductal invasive carcinoma 15
Aspetti ultrastrutturali ed immunochimici della componente vasale del timo in condizioni normali e patologiche 15
HSP110 Inhibition in Primary Effusion Lymphoma Cells: One Molecule, Many Pro-Survival Targets 15
Exogenous wt-p53 is stable and transcriptionally active in transformed cells but not in their non-transformed counterparts: implications for cancer gene therapy without tumor targeting 15
Exogenous wt-p53 protein is transcriptionally active in v-Ha-ras transformed C2C12 cells, but not in their non-transformed counterparts: a model for tumour gene therapy 15
p53 can inhibit cell proliferation through caspase-mediated cleavage of ERK2/MAPK 15
Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies 15
Hypoxia-inducible factor -1 (HIF-1) antagonizes p53-mediated apoptosis 15
Hyperglycemia triggers HIPK2 protein degradation 15
Role of fibronectin in the lysis mediated by NK cells 15
Zinc antagonizes HIF-1/VEGF signaling in vitro and in vivo 15
Ewing's sarcoma lines synthesize laminin and fibronectin 15
Zinc supplementation to chemotherapy of tumor cells restores p53 and HIPK2 activities, chemosensitivity and reduces tumor growth 15
Synthesis of laminin and fibronectin by Ewing's sarcoma lines 15
Zinc downregulates HIF-1α and inhibits its activity in tumor cells in vitro and in vivo 14
Tumor cell response to cisplatin requires HIPK2 and p53 phosphorylation at ser46 14
ERK2/MAPK, a new target for p53 in the cell cycle arrest 14
HIPK2 knock-down compromises tumor cell efficiency to repair damaged DNA 14
A fluorescent curcumin-based Zn(II)-complex reactivates mutant (R175H and R273H) p53 in cancer cells 14
Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death 14
Pyrazolone-Based Zn(II) Complexes Display Antitumor Effects in Mutant p53-Carrying Cancer Cells 14
Cisti odontogene dei mascellari: aspetti ultrastrutturali dello stroma 14
P53 activity in normal and tumor cells 14
Activation of p53/p21waf1 pathway is associated with senescence during v-Ha-ras transformation of immortal C2C12 myoblasts 14
Cytogenetic, molecular, immunologic, and ultrastructural study on an established cell line of a stage III neuroblastoma 14
Chloroquine supplementation increases the cytotoxic effect of curcumin against Her2/neu overexpressing breast cancer cells in vitro and in vivo in nude mice while counteracts it in immune competent mice 14
P53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions 14
The 72-kDa and the 92-kDa gelatinases, but not their inhibitors TIMP-1 and TIMP-2, are expressed in early psoriatic lesions 14
Expression and synthesis of fibronectin (FN) by rat NK cells: Possible involvement in the NK-target interaction 14
Analysis of alternative transcripts of human TIMP-2 gene using the polymerase chain reaction 14
Blockade of HIPK2 apoptotic function is involved in chemoresistance to cisplatin in ovarian cancer cells 14
Ruolo della fibronectina (FN) nell'interazione NK-cellula bersaglio 14
Kaposi sarcoma associated herpesvirus (KSHV) induces AKT hyperphosphorylation, bortezomib-resistance and GLUT-1 plasma membrane exposure in THP-1 monocytic cell line 13
Autophagy manipulation as a strategy for efficient anticancer therapies: Possible consequences 13
Gentian violet induces wtp53 transactivation in cancer cells 13
MDM2 transcriptional and posttranscriptional regulation by the HIPK2/p53 complex: a novel pathway for regulating p53 apoptotic function 13
Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells 13
Morphologic study of the vasal component of human thymus and thimoma 13
Novel approaches to target the p53 and hypoxia pathways for cancer therapy 13
Abrogation of p53 activity by HIPK2 down-regulation 13
Combination therapy strategies in HIPK2 knockdown tumor cells require Sirt1 inhibitor to activate p53 apoptotic transcription 13
Mutant p53 and cellular stress pathways: A criminal alliance that promotes cancer progression 13
Interplay between hypoxia and HIPK2/p53 signaling in tumor cells: molecular mechanisms and therapeutical implications 13
Laminin increase and localization during neural differentiation of a human neuroblastoma cell line 13
Inhibition of HIF-1alpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis 13
New kinases in the p53 pathway 13
Updates on HIPK2: a resourceful oncosuppressor for clearing cancer 13
NRF2 activation in BON‑1 neuroendocrine cancer cells reduces the cytotoxic effects of a novel Ruthenium(II)‑curcumin compound: A pilot study 13
A novel Zn(II)-compound reactivates mutant p53 protein in cancer cells: molecular mechanisms and therapeutical implications 13
Type IV collagenase activity promotes endothelial cell formation into capillary-like structures on basement membrane in vitro 13
HIPK2 contributes to PCAF-mediated acetylation of p53 after non-apoptotic DNA damage 13
Nuclear factor erythroid 2 (NF-E2) p45-related factor 2 interferes with homeodomain-interacting protein kinase 2/p53 activity to impair solid tumors chemosensitivity 13
Oxidant species are involved in T/B-mediated ERK1/2 phosphorylation that activates p53-p21 axis to promote KSHV lytic cycle in PEL cells 12
Il trasferimento genico di p53 induce iper-sensibilita‚ alle basse dosi di raggi X in cellule di glioblastoma: una nuova strategia per convertire il fenotipo radio-resistente in radio-sensibile 12
Recent Advances on Mutant p53: Unveiling Novel Oncogenic Roles, Degradation Pathways, and Therapeutic Interventions 12
Wt-p53 interferes with the v-Ha-ras pathway by inactivating ERK2/MAPK 12
Regulation of vascular endothelial growth factor expression by homeodomain-interacting protein kinase-2 12
Immunohistochemical and ultrastructural studies on the thymus in normal and acute EAE rats 12
Laminin synthesis by rat NK cells and T lymphocytes 12
Totale 1.555
Categoria #
all - tutte 14.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.676


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.311 0 0 0 24 51 21 91 74 267 46 345 392
2025/20261.409 266 36 352 351 404 0 0 0 0 0 0 0
Totale 2.720